iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Stock Price Up 1.8% – Still a Buy?

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) shot up 1.8% on Friday . The company traded as high as $31.41 and last traded at $31.21. 22,792 shares were traded during mid-day trading, a decline of 39% from the average session volume of 37,500 shares. The stock had previously closed at $30.66.

iShares Genomics Immunology and Healthcare ETF Stock Performance

The stock has a fifty day simple moving average of $29.54 and a 200-day simple moving average of $27.57. The stock has a market cap of $162.29 million, a P/E ratio of 14.76 and a beta of 1.03.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the company. Triumph Capital Management bought a new stake in iShares Genomics Immunology and Healthcare ETF during the third quarter worth $35,000. Ameriprise Financial Inc. raised its position in shares of iShares Genomics Immunology and Healthcare ETF by 8.4% in the third quarter. Ameriprise Financial Inc. now owns 71,473 shares of the company’s stock valued at $1,688,000 after buying an additional 5,540 shares in the last quarter. Finally, Portland Global Advisors LLC raised its position in shares of iShares Genomics Immunology and Healthcare ETF by 0.7% in the third quarter. Portland Global Advisors LLC now owns 103,007 shares of the company’s stock valued at $2,432,000 after buying an additional 684 shares in the last quarter.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.